Sanjit Agarwal
Overview
Explore the profile of Sanjit Agarwal including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
40
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gupta A, Bhardwaj S, Ghorai S, Ahmed R, Agarwal S, Mukherjee G, et al.
J Liq Biopsy
. 2025 Mar;
7:100287.
PMID: 40027231
Background: Liquid biopsy-based biomarkers offer several advantages since they are minimally invasive, can be useful in longitudinal monitoring of the disease and have higher patient compliance. We describe a protocol...
2.
Gupta R, Das J, Sinha S, Agarwal S, Sharma A, Ahmed R, et al.
Indian J Nucl Med
. 2023 Dec;
38(3):249-254.
PMID: 38046972
Aims: The aim of this study was to evaluate the role of F-2-fluoro-2-deoxy-D-glucose (F-FDG) positron emission tomography-computed tomography (PET-CT) scan in the detection of axillary lymph node (ALN) involvement and...
3.
Ganguly S, Mukherjee N, Mandal S, Roy S, Agarwal S, Biswas B, et al.
Ecancermedicalscience
. 2022 Nov;
16:1450.
PMID: 36405937
Purpose: Cyclin-dependent kinase 4/6 (CDK4/6) inhibitors have shown marked benefit in the treatment of hormone positive metastatic breast cancer (HR+ MBC). There are limited real-world studies with palbociclib and ribociclib....
4.
Jindal T, Pawar P, Agarwal S, Jain P, Meena M, Sarwal A, et al.
Urol Ann
. 2021 Nov;
13(4):391-396.
PMID: 34759652
Introduction: The association between inflammation and malignancies is being recognized. In this study, we assessed the use of preoperative neutrophil-lymphocyte ratio (NLR) and lymphocyte-monocyte ratio (LMR) in predicting cancer-specific survival...
5.
Ghosh J, Chatterjee M, Ganguly S, Datta A, Biswas B, Mukherjee G, et al.
Ecancermedicalscience
. 2021 Jun;
15:1217.
PMID: 34158821
Purpose: Triple-negative breast cancer (TNBC) has a poor outcome compared to other subtypes, even in those with early disease. Immune checkpoint inhibitors (ICIs) have been approved in metastatic diseases and...
6.
Banerjee S, Saha M, Arun I, Basak B, Agarwal S, Ahmed R, et al.
J Med Syst
. 2017 Aug;
41(9):144.
PMID: 28799130
This paper introducesnear-set based segmentation method for extraction and quantification of mucin regions for detecting mucinouscarcinoma (MC which is a sub type of Invasive ductal carcinoma (IDC)). From histology point...
7.
Mungle T, Tewary S, Arun I, Basak B, Agarwal S, Ahmed R, et al.
Comput Methods Programs Biomed
. 2017 Feb;
139:149-161.
PMID: 28187885
Ki-67 protein expression plays an important role in predicting the proliferative status of tumour cells and deciding the future course of therapy in breast cancer. Immunohistochemical (IHC) determination of Ki-67...
8.
Saha M, Arun I, Basak B, Agarwal S, Ahmed R, Chatterjee S, et al.
Tissue Cell
. 2016 Mar;
48(3):265-73.
PMID: 26971129
Mucinous carcinoma (MC) of the breast is very rare (∼1-7% of all breast cancers), invasive ductal carcinoma. Presence of pools of extracellular mucin is one of the most important histological...
9.
Khemka R, Chakraborty A, Ahmed R, Datta T, Agarwal S
A A Case Rep
. 2016 Mar;
6(9):280-2.
PMID: 26934607
Pecs block and its variations have been used for various breast surgeries. We describe 2 cases of mastectomy and breast reconstruction by latissimus dorsi (LD) flap where regional analgesia was...